DNX-04042

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameDNX-04042
Drug Alias NameJAK3 inhibitor (Dynamix)DNX-04000DNX-04042DNX-4000
ClassificationSmall molecules
Mechanisms of ActionImmunosuppressantsTyrosine-protein kinase JAK3 inhibitorsAnticancer protein kinase inhibitors
TargetsTyrosine-protein kinase JAK3
Therapy Area/IndicationsAutoimmune DiseasesArthritis, RheumatoidNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDynamix Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDynamix Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesArthritis, RheumatoidNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A